Medfinder
Back to blog

Updated: January 18, 2026

Naltrexone Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Calendar with medication bottle and availability graph

The naltrexone tablet shortage, ongoing since February 2024, is still affecting patients in 2026. Here's the latest update and what you need to know to protect your treatment.

The naltrexone shortage is real, and it's still happening. If you've been told your medication isn't available, or if you've been rationing your supply, this article explains what you need to know right now — and what you can do to protect your treatment.

Naltrexone Shortage Timeline: Where Are We Now?

The American Society of Health-System Pharmacists (ASHP) first posted a drug shortage bulletin for naltrexone hydrochloride tablets on February 29, 2024. The shortage has remained active through 2025 and into 2026.

Here's where things stand as of 2026:

Some manufacturers still have supply: Accord Healthcare, Major Pharmaceuticals, Sun Pharma, and Chartwell have available stock. These are real options — the challenge is that not all pharmacies stock from all manufacturers.

Some manufacturers have discontinued permanently: Avet Pharmaceuticals and Tagi Pharma have discontinued their naltrexone products entirely, reducing the total number of suppliers in the market.

Some NDCs remain in limited availability: As of late 2025, at least one manufacturer (Sun) reported certain NDC codes in limited availability with additional supply anticipated in early 2026.

Vivitrol is NOT in shortage: The injectable extended-release form (Vivitrol) has not been affected.

How Did the Shortage Start?

The shortage has two main drivers: demand growth and supply constraints.

On the demand side, pandemic-era increases in alcohol use disorder led to more patients seeking treatment, and expanded telehealth access made prescribing easier — which is good for patients, but it amplified demand faster than manufacturers could respond.

On the supply side, naltrexone requires thebaine — a DEA-regulated opium-derived compound — as a precursor. Thebaine is shared with more profitable medications like oxycodone and buprenorphine, meaning drug makers face competition for the same limited raw material. Naltrexone's low retail price (roughly $32-$90 for a 30-day supply with coupons) gives manufacturers little financial incentive to prioritize it.

The result: a medication that is vital for recovery but fragile in its supply chain.

How Does the Shortage Affect Patients in Recovery?

The shortage is not just an inconvenience — it is a real threat to patient safety. Naltrexone is a key component of medication-assisted treatment (MAT) for alcohol use disorder and opioid use disorder. Interruptions in treatment — even short ones — can increase the risk of relapse.

Particularly concerning: patients who stop naltrexone and then relapse to opioid use may face an elevated risk of overdose. After a period on naltrexone, opioid tolerance is reduced. If a patient returns to the same dose they used before starting naltrexone, they may experience fatal respiratory depression.

What Should You Do If You're Running Low?

Take these steps immediately:

Contact your prescriber now — before you run out. Let them know you're having trouble filling your prescription so they can help you plan ahead or switch formulations if necessary.

Call multiple pharmacies in your area — availability varies widely. Independent pharmacies and grocery chain pharmacies may have stock when major chains do not.

Use medfinder.com to locate pharmacies with naltrexone in stock. medfinder calls pharmacies near you and texts you the results.

Ask about Vivitrol — the monthly injectable form is currently available. Ask your prescriber if it's appropriate for you.

Request a 90-day supply when you do find stock. Some insurance plans allow extended supplies at lower cost.

Will the Shortage End in 2026?

Some positive signs are emerging. A few manufacturers have indicated that additional supply is expected in early 2026 for certain product forms. However, the underlying structural problems — regulated thebaine quotas, low profit margins, and manufacturer consolidation — have not been resolved. Patients should continue to be proactive about securing their supply.

The best protection against the shortage is planning ahead: request refills early, know which backup pharmacies in your area stock naltrexone, and have a conversation with your prescriber about Vivitrol or other options in case the situation worsens.

Find Naltrexone Near You

If you need help finding which pharmacies near you have naltrexone in stock today, medfinder.com can search for you. You provide your medication and location, medfinder calls pharmacies, and you receive a text with the results.

Also see: Why Is Naltrexone So Hard to Find? [Explained for 2026].

Frequently Asked Questions

Yes. The naltrexone oral tablet shortage remains active as of 2026. It was first reported in February 2024. While some manufacturers (Accord, Major, Sun, Chartwell) still have available stock, others have permanently discontinued their products. Availability varies from pharmacy to pharmacy and region to region.

There is no confirmed end date for the naltrexone shortage. Some manufacturers indicated additional supply was expected in early 2026, but the underlying causes — regulated thebaine quotas, low profit margins, and manufacturer consolidation — have not been fully addressed. Patients should continue planning ahead.

No. Vivitrol, the brand-name 380 mg monthly injectable naltrexone, is not affected by the current shortage. If you are struggling to find oral tablets, ask your provider whether Vivitrol might be an option for you.

Do not stop naltrexone abruptly without talking to your prescriber. Stopping naltrexone — especially for patients with OUD — increases the risk of relapse, and relapsing after stopping naltrexone can be dangerous because your opioid tolerance is reduced. Contact your provider before you run out so they can help you plan.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Naltrexone also looked for:

35,181 have already found their meds with Medfinder.

Start your search today.

35K+
5-star ratingTrusted by 35,181 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?